Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment

Scientific Reports- United Kingdom

doi 10.1038/s41598-019-40153-0

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Mechanism of Hepatic Insulin Resistance in Non-Alcoholic Fatty Liver Disease

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver Disease

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Options of Dyslipidemia Treatment at Non-Alcoholic Fatty Liver Disease

Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii
2016English

Republished: Non-Alcoholic Fatty Liver Disease: A Practical Approach to Treatment

Postgraduate Medical Journal
Medicine
2015English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease; A Systematic Review on the Current Evidences

Hepatitis Monthly
HepatologyInfectious Diseases
2013English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy